Feb 18, 2016 22:12 pm UTC| Business
RALEIGH N.C., Feb. 18, 2016 -- PRA Holdings, Inc. (“PRA Holdings”), a wholly-owned subsidiary of PRA Health Sciences, Inc. (“PRA”) (NASDAQ: PRAH), today announced that it has commenced a cash tender offer for up to $75...
Famous Dave’s of America Announces the Appointment of Alfredo Martel as Chief Marketing Officer
Feb 18, 2016 22:05 pm UTC| Business
MINNEAPOLIS, Feb. 18, 2016 -- Famous Dave's of America, Inc.(NASDAQ:DAVE) today announced the appointment of Alfredo Martel as Chief Marketing Officer. An industry leader with broad experience in brand building,...
Famous Dave's Fourth Quarter 2015 Earnings Release and Conference Call
Feb 18, 2016 22:05 pm UTC| Business
MINNEAPOLIS, Feb. 18, 2016 -- Famous Dave's of America, Inc. (NASDAQ:DAVE) (“Famous Dave’s” or the “Company”) will announce its fourth quarter 2015 financial results at 3:00 p.m., Central Time on February 24, 2016. The...
Chemung Financial Announces Quarterly Dividend
Feb 18, 2016 22:05 pm UTC| Business
ELMIRA, N.Y., Feb. 18, 2016 -- Chemung Financial Corporation (Nasdaq:CHMG) announced today that its Board of Directors has approved a quarterly cash dividend of $0.26 per share, payable on April 1, 2016 to common stock...
Crown Castle Declares Quarterly Common Stock Dividend
Feb 18, 2016 22:00 pm UTC| Business
HOUSTON, Feb. 18, 2016 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today that its Board of Directors has declared a quarterly cash dividend of $0.885 per common share. The quarterly...
Erickson Broadens Customer Service and Business Development Prowess
Feb 18, 2016 22:00 pm UTC| Business
PORTLAND, Ore., Feb. 18, 2016 -- Erickson Incorporated (NASDAQ:EAC), a leading global provider of aviation services, continues to expand its expertise and talent with the appointment of leadership and sales personnel...
Aptose to Present at the 2016 RBC Capital Markets Global Healthcare Conference
Feb 18, 2016 22:00 pm UTC| Business
SAN DIEGO and TORONTO, Feb. 18, 2016 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...